SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-000899
Filing Date
2018-02-20
Accepted
2018-02-20 16:33:20
Documents
66
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234199z10-k.htm 10-K 1381488
2 EX-23.1 a2234199zex-23_1.htm EX-23.1 5471
3 EX-31.1 a2234199zex-31_1.htm EX-31.1 7869
4 EX-31.2 a2234199zex-31_2.htm EX-31.2 7901
5 EX-32.1 a2234199zex-32_1.htm EX-32.1 4495
12 G373333.JPG g373333.jpg GRAPHIC 42205
  Complete submission text file 0001047469-18-000899.txt   7075863

Data Files

Seq Description Document Type Size
6 EX-101.INS espr-20171231.xml EX-101.INS 1904640
7 EX-101.SCH espr-20171231.xsd EX-101.SCH 39516
8 EX-101.CAL espr-20171231_cal.xml EX-101.CAL 54292
9 EX-101.DEF espr-20171231_def.xml EX-101.DEF 147596
10 EX-101.LAB espr-20171231_lab.xml EX-101.LAB 441492
11 EX-101.PRE espr-20171231_pre.xml EX-101.PRE 301094
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 18625156
SIC: 2834 Pharmaceutical Preparations